Actionable news
All posts from Actionable news

Investor’s Alert on Notable Stocks – Great Basin Scientific (NASDAQ:GBSN), Wells Fargo (NYSE:WFC), Kinross Gold (NYSE:KGC)

On Thursday, Shares of Great Basin Scientific Inc (NASDAQ:GBSN), gained 9.19% to $0.0891. The stock attained the volume of 36.96 million shares.

Great Basin Scientific, Inc. (GBSN), a molecular diagnostics company, declared that the Company has presented its Shiga Toxin Direct Test to the U.S. Food & Drug Administration (FDA) for 510(k) clearance following the successful completion of a clinical trial that met all of Great Basin’s clinical objectives. Upon clearance, the test will be the only stand-alone molecular test to detect Shiga toxin-producing E. coli and the serotype O157 directly from a patient specimen.

The Centers for Disease Control (CDC) reports STEC is a leading cause of bacterial enteric infections in the U.S., and in 2009, issued a recommendation that all stools presented for testing from patients with acute community-attained diarrhea should be cultured for STEC O157. These stools should be simultaneously assayed for non-O157 STEC with a test that detects Shiga toxins or the genes encoding these toxins. Conventional laboratory culture-based testing for STEC can be laborious and time-consuming, taking 48-96 hours to prepare and process the tests. The CDC states that prompt, accurate diagnosis of a STEC infection is imperative to reduce further infection or kidney damage, and to determine the best course of care, as antibiotic therapy in patients with STEC infections might result in more severe disease.

Great Basin Scientific, Inc., a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic...